STELLANTIS NV (8TI.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:8TI • NL00150001Q9

8.188 EUR
-0.49 (-5.64%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

2

Taking everything into account, 8TI scores 2 out of 10 in our fundamental rating. 8TI was compared to 33 industry peers in the Automobiles industry. 8TI may be in some trouble as it scores bad on both profitability and health. 8TI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year 8TI has reported negative net income.
  • In the past year 8TI has reported a negative cash flow from operations.
  • 8TI had positive earnings in each of the past 5 years.
  • Each year in the past 5 years 8TI had a positive operating cash flow.
8TI.DE Yearly Net Income VS EBIT VS OCF VS FCF8TI.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

  • 8TI has a Return On Assets of -1.19%. This is in the lower half of the industry: 8TI underperforms 69.70% of its industry peers.
  • 8TI has a worse Return On Equity (-3.27%) than 66.67% of its industry peers.
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROIC N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
8TI.DE Yearly ROA, ROE, ROIC8TI.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • 8TI's Profit Margin has declined in the last couple of years.
  • 8TI's Operating Margin has declined in the last couple of years.
  • The Gross Margin of 8TI (7.74%) is worse than 78.79% of its industry peers.
  • In the last couple of years the Gross Margin of 8TI has remained more or less at the same level.
  • 8TI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.74%
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
8TI.DE Yearly Profit, Operating, Gross Margins8TI.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. Health

2.1 Basic Checks

  • 8TI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, 8TI has less shares outstanding
  • 8TI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 8TI has a worse debt to assets ratio.
8TI.DE Yearly Shares Outstanding8TI.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
8TI.DE Yearly Total Debt VS Total Assets8TI.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

  • Based on the Altman-Z score of 1.33, we must say that 8TI is in the distress zone and has some risk of bankruptcy.
  • 8TI has a better Altman-Z score (1.33) than 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.38 indicates that 8TI is not too dependend on debt financing.
  • 8TI has a Debt to Equity ratio of 0.38. This is in the better half of the industry: 8TI outperforms 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.33
ROIC/WACCN/A
WACC6.88%
8TI.DE Yearly LT Debt VS Equity VS FCF8TI.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

  • 8TI has a Current Ratio of 1.06. This is a normal value and indicates that 8TI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.06, 8TI is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.77 indicates that 8TI may have some problems paying its short term obligations.
  • The Quick ratio of 8TI (0.77) is worse than 75.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.77
8TI.DE Yearly Current Assets VS Current Liabilites8TI.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

3

3. Growth

3.1 Past

  • The earnings per share for 8TI have decreased strongly by -118.87% in the last year.
  • 8TI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.26% yearly.
  • 8TI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.07%.
  • Measured over the past years, 8TI shows a small growth in Revenue. The Revenue has been growing by 7.72% on average per year.
EPS 1Y (TTM)-118.87%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%

3.2 Future

  • Based on estimates for the next years, 8TI will show a small growth in Earnings Per Share. The EPS will grow by 4.74% on average per year.
  • The Revenue is expected to grow by 3.67% on average over the next years.
EPS Next Y-95.93%
EPS Next 2Y-19.62%
EPS Next 3Y-1.29%
EPS Next 5Y4.74%
Revenue Next Year-2.26%
Revenue Next 2Y1.53%
Revenue Next 3Y2.37%
Revenue Next 5Y3.67%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
8TI.DE Yearly Revenue VS Estimates8TI.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50B 100B 150B 200B
8TI.DE Yearly EPS VS Estimates8TI.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for 8TI. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 5.57, which indicates a rather cheap valuation of 8TI.
  • 75.76% of the companies in the same industry are more expensive than 8TI, based on the Price/Forward Earnings ratio.
  • 8TI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
Industry RankSector Rank
PE N/A
Fwd PE 5.57
8TI.DE Price Earnings VS Forward Price Earnings8TI.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 8TI is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.63
8TI.DE Per share data8TI.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.62%
EPS Next 3Y-1.29%

0

5. Dividend

5.1 Amount

  • No dividends for 8TI!.
Industry RankSector Rank
Dividend Yield 0%

STELLANTIS NV

FRA:8TI (2/5/2026, 7:00:00 PM)

8.188

-0.49 (-5.64%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)01-05
Earnings (Next)02-26
Inst Owners45.78%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap23.71B
Revenue(TTM)146.12B
Net Income(TTM)-2.39B
Analysts70.86
Price Target9.91 (21.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.34
Dividend Growth(5Y)N/A
DP-81.93%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.94%
PT rev (3m)5.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)152.7%
EPS NY rev (3m)-76.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.57
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 1.02
EV/EBITDA 6.63
EPS(TTM)-0.83
EYN/A
EPS(NY)1.47
Fwd EY17.95%
FCF(TTM)-4.68
FCFYN/A
OCF(TTM)-1.05
OCFYN/A
SpS50.46
BVpS25.25
TBVpS8.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.74%
FCFM N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.66%
ROCE(5y)12.71%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
F-Score1
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 6.13
Cap/Depr 145.84%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.77
Altman-Z 1.33
F-Score1
WACC6.88%
ROIC/WACCN/A
Cap/Depr(3y)140.23%
Cap/Depr(5y)152.03%
Cap/Sales(3y)5.82%
Cap/Sales(5y)6.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.87%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
EPS Next Y-95.93%
EPS Next 2Y-19.62%
EPS Next 3Y-1.29%
EPS Next 5Y4.74%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%
Revenue Next Year-2.26%
Revenue Next 2Y1.53%
Revenue Next 3Y2.37%
Revenue Next 5Y3.67%
EBIT growth 1Y-115.72%
EBIT growth 3Y-27.78%
EBIT growth 5Y0.11%
EBIT Next Year16.35%
EBIT Next 3Y25.98%
EBIT Next 5Y20.26%
FCF growth 1Y-193.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.94%
OCF growth 3Y-40.45%
OCF growth 5Y-18.8%

STELLANTIS NV / 8TI.DE FAQ

Can you provide the ChartMill fundamental rating for STELLANTIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to 8TI.DE.


What is the valuation status for 8TI stock?

ChartMill assigns a valuation rating of 3 / 10 to STELLANTIS NV (8TI.DE). This can be considered as Overvalued.


How profitable is STELLANTIS NV (8TI.DE) stock?

STELLANTIS NV (8TI.DE) has a profitability rating of 2 / 10.


What is the financial health of STELLANTIS NV (8TI.DE) stock?

The financial health rating of STELLANTIS NV (8TI.DE) is 2 / 10.